Page last updated: 2024-08-25

ubenimex and cytarabine

ubenimex has been researched along with cytarabine in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Leyhausen, G; Maidhof, A; Müller, WE; Schröder, HC; Schuster, DK; Umezawa, H1
Hashimoto, I; Oka, T; Tanaka, T1
Kurita, S; Masaoka, T; Ogawa, N; Ota, K; Uzuka, Y; Yamada, K1
Asou, N; Emi, N; Hiraoka, A; Jinnai, I; Kageyama, S; Kanamaru, A; Kobayashi, T; Kuriyama, K; Matsuoka, A; Minami, S; Minato, K; Miyawaki, S; Murakami, H; Naoe, T; Oh, H; Ohmoto, E; Ohno, R; Saito, K; Sakamaki, H; Takahashi, I; Tanimoto, M; Tomonaga, M; Tsubaki, K; Yamada, O; Yoshida, M1
Abe, F; Fujii, H; Maruyama, S; Yosizawa, K1
Chiba, H; Hirayama, Y; Matsunaga, T; Niitsu, Y; Sagawa, T; Sakamaki, S; Takayanagi, N; Tsuji, Y1

Trials

3 trial(s) available for ubenimex and cytarabine

ArticleYear
[Randomized controlled trial of postoperative adjuvant chemotherapy with bestatin for gastric cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:1

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cytarabine; Female; Gastrectomy; Humans; Leucine; Male; Middle Aged; Mitomycin; Mitomycins; Postoperative Care; Prognosis; Random Allocation; Stomach Neoplasms; Tegafur

1985
[Results of follow-up studies on prognosis after immunotherapy with bestatin in acute nonlymphocytic leukemia].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:4 Pt 1

    Topics: Aclarubicin; Acute Disease; Adjuvants, Immunologic; Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Follow-Up Studies; Humans; Leucine; Leukemia; Mercaptopurine; Middle Aged; Naphthacenes; Prednisolone; Prognosis; Random Allocation

1986
Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. The Japan Leukemia Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chi-Square Distribution; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leucine; Leukemia, Myeloid; Logistic Models; Male; Mercaptopurine; Middle Aged; Multivariate Analysis; Prednisolone; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome

1996

Other Studies

3 other study(ies) available for ubenimex and cytarabine

ArticleYear
Potentiation of the bleomycin, arabinofuranosylcytosine and adriamycin-caused inhibition of DNA synthesis in lymphocytes by bestatin in vitro.
    European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:11

    Topics: Animals; Bleomycin; Cell Line; Cell Survival; Cells, Cultured; Cytarabine; Depression, Chemical; DNA; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Leucine; Lymphocytes; Macrophages; Male; Mice; Thymidine

1985
[Growth inhibitory effects of ubenimex on leukemic cell lines resistant to chemotherapeutic agents].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:12

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Division; Cytarabine; Daunorubicin; Depression, Chemical; Drug Combinations; Drug Resistance, Neoplasm; Drug Synergism; Humans; Leucine; Leukemia, Myeloid, Acute; Mercaptopurine; Tumor Cells, Cultured

1996
[Chemotherapy with ubenimex corresponding to patient age and organ disorder for 18 cases of acute myelogeneous leukemia in elderly patients--effects, complications and long-term survival].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:8

    Topics: Aclarubicin; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Leucine; Leukemia, Myeloid, Acute; Male; Remission Induction; Survival Rate

2003